ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CERE Cerevel Therapeutics Holdings Inc

42.55
-0.04 (-0.09%)
May 03 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -64.49M-72.53M-93.01M-95.07M-107.25M-99.55M-96.84M-111.31M
Pre Tax Income -59.06M-68.29M-90.47M-99.94M-92.65M-104.2M-99.43M-96.24M
Net Income -59.06M-68.29M-90.47M-99.94M-92.81M-104.29M-99.54M-96.36M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -57.67M-72.53M-93M-96.84M-107.25M-99.56M-96.85M-111.31M
EBITDA -63.4M-71.41M-91.78M-93.8M-105.95M-98.23M-95.49M-109.86M
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000
Operating Income -149.12M-220.1M-367.85M-447.27M
Pre Tax Income -152.17M-225.33M-351.35M-432.34M
Net Income -148.27M-225.33M-351.51M-432.84M
Preferred Dividends 3.87M000
Basic Earnings Per Share (EPS) -1.119-1.471-2.171-2.331
EBIT -152.39M-220.11M-367.85M-447.29M
EBITDA -148.72M-217.37M-362.95M-441.64M

Your Recent History

Delayed Upgrade Clock